VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner. Oncogene. 2017 07 13; 36(28):4081-4086.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
B-Lymphocytes
Cancer Vaccines
Drug Antagonism
Female
gp100 Melanoma Antigen
Immunotherapy
Indoles
Melanoma
Mice
Mice, Inbred C57BL
Oligodeoxyribonucleotides
Protein Kinase Inhibitors
Proto-Oncogene Proteins B-raf
Sulfonamides
Toll-Like Receptor 9
Tumor Cells, Cultured
Vaccines, Subunit
authors with profiles
PATRICK HWU